Oral mucositis (OM) is a common side effect experienced during haematopoietic SCT(HSCT), and it can have a significant impact on the quality of life of patients. A descriptive nurse-led study was undertaken in 19-member centres of the Italian national transplant group (GITMO) evaluating incidence, severity and duration of OM in patients undergoing HSCT. Data from 1841 patients between 2002 and 2006 was analyzed. Initial medical history and oral cavity assessment was performed. Assessment was repeated on the day of transplant, then daily, using the WHO (World Health Organisation) oral toxicity scale. A total of 71% of the patients evaluated developed mucositis and 21.6% developed severe mucositis. Duration of OM in most cases lasted for 10-14 days and resolved along with marrow reconstitution. Oral mucostitis is a frequent side effect in patients undergoing HSCT. The onset of severe mucositis seems to be related to the conditioning regimen used. This database provides a descriptive overview of the incidence and severity of mucositis and has encouraged participating centres to adopt routine evaluation and measurement of the oral cavity. The assessment tools are still used in some centres, providing a basis for further collaborative research projects.

Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT (HSCT)-results of a multicentre study.

VAGLIANO, LILIANA;ORLANDO, Luca;DIMONTE, Valerio
2011

Abstract

Oral mucositis (OM) is a common side effect experienced during haematopoietic SCT(HSCT), and it can have a significant impact on the quality of life of patients. A descriptive nurse-led study was undertaken in 19-member centres of the Italian national transplant group (GITMO) evaluating incidence, severity and duration of OM in patients undergoing HSCT. Data from 1841 patients between 2002 and 2006 was analyzed. Initial medical history and oral cavity assessment was performed. Assessment was repeated on the day of transplant, then daily, using the WHO (World Health Organisation) oral toxicity scale. A total of 71% of the patients evaluated developed mucositis and 21.6% developed severe mucositis. Duration of OM in most cases lasted for 10-14 days and resolved along with marrow reconstitution. Oral mucostitis is a frequent side effect in patients undergoing HSCT. The onset of severe mucositis seems to be related to the conditioning regimen used. This database provides a descriptive overview of the incidence and severity of mucositis and has encouraged participating centres to adopt routine evaluation and measurement of the oral cavity. The assessment tools are still used in some centres, providing a basis for further collaborative research projects.
46
5
727
732
http://www.nature.com/bmt/journal/vaop/ncurrent/full/bmt2010184a.html
oral mucositis; SCT; WHO oral toxicity scale
Vagliano L; Feraut C; Gobetto G; Trunfio A; Errico A; Campani V; Costazza G; Mega A; Matozzo V; Berni M; Alberani F; Banfi MM; Martinelli L; Orlando L; Dimonte V.
File in questo prodotto:
File Dimensione Formato  
ID_505365.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 321.53 kB
Formato Adobe PDF
321.53 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/82984
Citazioni
  • ???jsp.display-item.citation.pmc??? 17
  • Scopus 63
  • ???jsp.display-item.citation.isi??? 56
social impact